Search By Initial

Cas Index 2

• 2765081-21-6 | RMC-6236 (Catalog# : 25074)Daraxonrasib, also known as RMC-6236 and RAS-IN-2, is a potent and selective RAS(ON)
• 266359-83-5 | Reparixin (Catalog# : 25050)Reparixin is an inhibitor of CXCR2 function, which attenuates inflammatory responses
• 2794934-49-7 | RGT-018 (Catalog# : 24148)RGT-018 is a potent and orally active SOS1 inhibitor with anti-tumor effects.
• 2204289-53-0 | (Rac)-SHIN2 (Catalog# : 24136)(Rac)-SHIN2 is a serine hydroxymethyltransferase (SHMT) inhibitor having 1,4-dihydrop
• 2642037-07-6 | RMC-4998 (Catalog# : 20666)RMC-4998 is a tri-complex inhibitor and KRASG12C inhibitor. RMC-4998 targets the acti
• 2503036-46-0 | RNK-05047 (Catalog# : 24008)RNK-05047 is a PROTAC degrader of BRD4 which displays significant tumor growth inhibi
• 2750709-91-0 | Resigratinib (Catalog# : 20627)Resigratinib is a fibroblast growth factor receptor tyrosine kinase inhibitor and ant
• 2031185-00-7 | Risvodetinib (Catalog# : 20621)Risvodetinib, also known as IkT-148009., is a brain-penetrant c-Abl inhibitor with a
• 2366152-15-8 | RPT193 (Catalog# : 20526)
• 2192215-81-7 | Ritlecitinib tosylate (Catalog# : 20452)Ritlecitinib, also known as PF-06651600, is a potent and selective JAK3 inhibitor. PF
• 2171386-10-8 | RK-287107 (Catalog# : 2071520)RK-287107 is a potent TNKS/TNKS2 inhibitor (IC50 = 14.4 nM) with >7000-fold select
• 2381037-82-5 | RBN-2397 (Catalog# : 207101)
• 2161337-98-8 | (2R,6S)-tert-butyl 4-(4-aminobenzoyl)-2,6-dimethylpiperazine-1-carboxylate (Catalog# : 2062334)
• 243984-11-4 | Resatorvid (Catalog# : 206102)Resatorvid, also known as TAK-242, is a cell-permeable inhibitor of TLR4 signaling, b
• 2262452-06-0 | RU320521 (Catalog# : 204503)RU320521, also known as RU521; RU.521 is a potent and selective inhibitor of cGAS, in
• 2086689-88-3 | (R)-tert-butyl 2-(2-ethynyl-2-methylpyrrolidin-1-yl)acetate (Catalog# : 580586)(R)-tert-butyl 2-(2-ethynyl-2-methylpyrrolidin-1-yl)acetate, CAS 2086689-88-3, is a v
• 2072057-17-9 | RG7834 (Catalog# : 19355)RG7834，also known as RO7020322, is a novel oral HBV viral gene expression inhibitor
• 252889-88-6 | RWJ-56110 (Catalog# : 19353)RWJ-56110 is a selective protease-activated receptor-1 (PAR1) antagonist. It blocks t
• 259188-38-0 | Rebimastat (Catalog# : 192254)Rebimastat, also known as BMS275291, is a sulfhydryl-based second-generation matrix m
• 2172651-73-7 | RMC-4550 (Catalog# : 186251)RMC-4550 is a potent and selective SHP2 inhibitor.
• 2133832-83-2 | R-IMPP (Catalog# : 18413)R-IMPP is an inhibitor of PCSK9 translation.
• 2003234-63-5 | R-GNE-140 (Catalog# : 18432)R-GNE-140 a novel potent lactate dehydrogenase (LDHA) inhibitor with IC50 3nM for LDH
• 2097334-19-3 | (2R,14R)-4-((R)-1-((R)-4-benzyl-2-oxooxazolidin-3-yl)-3-(tert-butoxycarbonyl)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate (Catalog# : 183217)(2R,14R)-4-((R)-1-((R)-4-benzyl-2-oxooxazolidin-3-yl)-3-(tert-butoxycarbonyl)-1-oxopr
• 2097334-18-2 | (R)-4-(2-(4-benzyl-2-oxooxazolidin-3-yl)-2-oxoethyl)benzyl 2,4-dimethylbenzoate (Catalog# : 183216)(R)-4-(2-(4-benzyl-2-oxooxazolidin-3-yl)-2-oxoethyl)benzyl 2,4-dimethylbenzoate is a
• 269730-03-2 | RPI-1 (Catalog# : 17030301)RPI-1 is an ATP-dependent RET kinase inhibitor. Oral treatment with RPI-1 caused grow
• 283173-50-2 | Rucaparib (Catalog# : 123005)Rucaparib is an inhibitor of PARP with Ki of 1.4 nM for PARP1, also showing binding a
• 27298-99-3 | (1R)-1-(4-chlorophenyl)ethanamine (Catalog# : 91124)Coming soon!
• 239105-47-6 | (1R)-1-(4-methylphenyl)propan-1-amine,hydrochloride (Catalog# : 91106)Coming soon!
• 23844-66-8 | (1R)-2-methyl-1-phenylpropan-1-amine (Catalog# : 91103)Coming soon!
• 278788-60-6 | (2R)-1-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-2-carboxylic acid (Catalog# : 81724)Coming soon!